Correlation Between Vincerx Pharma, and Molecular Partners
Can any of the company-specific risk be diversified away by investing in both Vincerx Pharma, and Molecular Partners at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vincerx Pharma, and Molecular Partners into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vincerx Pharma, Common and Molecular Partners AG, you can compare the effects of market volatilities on Vincerx Pharma, and Molecular Partners and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vincerx Pharma, with a short position of Molecular Partners. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vincerx Pharma, and Molecular Partners.
Diversification Opportunities for Vincerx Pharma, and Molecular Partners
-0.73 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Vincerx and Molecular is -0.73. Overlapping area represents the amount of risk that can be diversified away by holding Vincerx Pharma, Common and Molecular Partners AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Molecular Partners and Vincerx Pharma, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vincerx Pharma, Common are associated (or correlated) with Molecular Partners. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Molecular Partners has no effect on the direction of Vincerx Pharma, i.e., Vincerx Pharma, and Molecular Partners go up and down completely randomly.
Pair Corralation between Vincerx Pharma, and Molecular Partners
Given the investment horizon of 90 days Vincerx Pharma, Common is expected to under-perform the Molecular Partners. In addition to that, Vincerx Pharma, is 2.23 times more volatile than Molecular Partners AG. It trades about -0.03 of its total potential returns per unit of risk. Molecular Partners AG is currently generating about 0.03 per unit of volatility. If you would invest 435.00 in Molecular Partners AG on September 7, 2025 and sell it today you would earn a total of 17.00 from holding Molecular Partners AG or generate 3.91% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 98.99% |
| Values | Daily Returns |
Vincerx Pharma, Common vs. Molecular Partners AG
Performance |
| Timeline |
| Vincerx Pharma, Common |
| Molecular Partners |
Vincerx Pharma, and Molecular Partners Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Vincerx Pharma, and Molecular Partners
The main advantage of trading using opposite Vincerx Pharma, and Molecular Partners positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vincerx Pharma, position performs unexpectedly, Molecular Partners can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Molecular Partners will offset losses from the drop in Molecular Partners' long position.| Vincerx Pharma, vs. Klegg Electronics | Vincerx Pharma, vs. Pembina Pipeline | Vincerx Pharma, vs. ICL Israel Chemicals | Vincerx Pharma, vs. Cabo Drilling Corp |
| Molecular Partners vs. Renewable Energy Trade | Molecular Partners vs. PARKSON Retail Group | Molecular Partners vs. Day Tradexchange | Molecular Partners vs. Flow Traders |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Other Complementary Tools
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |